Keyword: India

Plant Construction & Process Technology

Biosimilars on Their Way into Global Biopharmaceuticals Market

20.11.2012 - With an introduction to the U.S. set for 2014, and the realization of massive potential in the emerging markets of Asia, biosimilars are set to take a sizable chunk of the global...

News

India's Gulf Oil Buys US Chemicals Company for $1 Billion

07.11.2012 - Indian lubricants maker Gulf Oil said on Tuesday it has acquired U.S.-based specialty chemicals company Houghton International from a private equity fund for $1.05 billion. Gulf...

News

India Revokes Roche Patent in New Blow for Big Pharma

03.11.2012 - India dealt a fresh blow to the international pharmaceutical industry on Friday as its patents appeal board revoked a patent granted six years ago on Roche's hepatitis C drug...

News

Dr. Reddy's Q2 Profit Jumps on New Drugs

30.10.2012 - Dr. Reddy's Laboratories, India's No. 2 drugmaker by sales, reported a better-than-expected 32% rise in quarterly net profit as four new generic drugs drove sales in North America...

News

Indian Rain Commodities to Buy German-Owned Ruetgers

23.10.2012 - Indian industrial group Rain Commodities agreed to buy speciality chemicals group Ruetgers in a €702 million ($918 million) deal that would set a new record for an Indian takeover...

News

IndianOil, KOGAS Sign Agreement for LNG and E&P Ventures

19.10.2012 - IndianOil and Korea Gas Corporation (KOGAS) signed an MoU for joint participation in exploration and production of gas and oil at the global level and developing natural gas...

News

India's BPCL to Spend More than $3 Billion on Expansion of Refineries

11.10.2012 - India's second largest refiner, Bharat Petroleum (BPCL), will complete expansion projects costing more than $3 billion at two refineries by 2015, as it moves to boost output and...

Chemistry & Life Sciences

India and China support Contract Manufacturing

25.09.2012 - Today's pharmaceutical industry is flooded with numerous CMOs, with Asian countries being the prime focus for big pharmaceutical companies looking to outsource. This is primarily...